Drug Delivery

Pharmaceutical companies face substantial challenges, from constraints in health spending to weakening drug pipelines. Yet opportunities exist for those bold enough to adapt, ranging from connected devices that drive adherence to generic devices at cost points previously thought impossible.

Drug Delivery
I

Innovator pharmaceutical and biotech companies face an increasingly complex pipeline of therapies that require innovative means of delivery. These range from targeting precision dosages to a tumour, to delivering large volumes of biologics subcutaneously. 

Confronted with increasing cost pressures from payers, these same companies must also work hard to generate the clinical and economic evidence necessary to support the value and price of their products. A focus on real-world evidence means products have expanded beyond the drug, to include devices and digital services that drive adherence and improve outcomes.

Generics companies are seizing the opportunity to exploit off-patent drugs. The value proposition of a generic product is predefined, but its development provides significant challenges. Device patents provide substantial barriers and bioequivalence is hard to achieve. Timing is critical - and competition is fierce.

TTP is working with clients at all stages of the product development life cycle. From helping companies to explore and define new business opportunities, through to using a first principles approach to troubleshoot late stage problems in scale-up and commercialisation. But in all cases using highly skilled, multidisciplinary teams to develop market leading products and services routinely.

Explore More industries

Life Science

We work at the intersection of physics, engineering and the biological sciences, creating and developing new technology for the life science industry.

Medical Devices

Disruptive change is rolling through the medical device industry as value-based healthcare and digitisation spread from niches to the mainstream. This is a challenging time, but it presents real opportunities for those ambitious companies prepared to reinvent themselves.

In-vitro Diagnostics

The diagnostic market is at a moment of change. New approaches, such as sequencing, are gaining traction; companion diagnostics are driving closer integration with therapy; continuous monitoring is enabling new diagnostic information; and market drivers are demanding low cost distribution of clinical quality data.

Bioprocess

Human therapies are adapting to tackle increasingly complex immunological diseases and conditions. These therapies often rely on tightly controlled cell cultures in order to produce therapeutic drugs efficiently, such as monoclonal antibodies or culture of the patient’s own genetically-engineered cells, as part of an autologous cell therapy workflow.

Biosensors

Emerging biosensor technologies are enabling the measurement and analysis of valuable trace markers, leading to improved clinical outcomes by allowing the accurate observation of previously undetectable physiological signals.

Smart Implants

Increasing numbers of people are suffering from chronic conditions. Through the creation of tiny, fully integrated real-time measurement systems, smart implants are bringing the benefits of laboratory-grade telemetry to their lives.

Digital Health

As with other industries, digital technology is touching every aspect of healthcare. But health is unique in its complexity, and innovation requires deep insight.

Medical Imaging

Medical imaging is required to meet the needs of advanced diagnostics and the demands of emerging markets, presenting the sector with sizeable rewards for innovation.

Surgical

Surgery is a fertile area for medical device innovation with remarkable developments occurring in minimally invasive and robotic assisted techniques. The future of the operating room relies on intraoperative technologies which improve clinical and economic values as measured by procedure outcome, workflow efficiency and patient safety.

Get in touch

We use cookies to improve your experience on our site. To find out more, read our updated privacy policy. More information.